RedChip Featured Company: Pipex Pharmaceuticals, Inc. (PP)
Pipex Pharmaceuticals, Inc. (PP) is a specialty pharmaceutical company focused on developing proprietary, late-stage treatments for central nervous system and autoimmune diseases. The company hopes to complete clinical testing, along with manufacturing and regulatory requirements, to seek marketing authorizations through the filing of new drug applications (NDA) with the FDA and marketing application authorizations with the European Medicines Evaluation Agency. A key element of Pipex’s strategy is to perform efficient and timely development of their clinical-stage drug candidates through the selection of initial indications that represent high-profile, unmet medical needs. Upon approval, the drug candidate's scope may be expanded to…
